<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; Uncategorized</title>
	<atom:link href="http://q-pharm.com/category/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 03 Feb 2012 10:47:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>MA/p17 HIV matrix protein is a promising target for drug discovery</title>
		<link>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/</link>
		<comments>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 14:00:43 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=385</guid>
		<description><![CDATA[As a result of the analysis of HIV virus targets, the most conservative among all the possible HIV-1 virus target protein—p17/MA (see figure)—was selected. This is a matrix (structural) protein, [...]


Related posts:<ol><li><a href='http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/' rel='bookmark' title='New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1'>New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1</a></li>
<li><a href='http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/' rel='bookmark' title='Influenza matrix M1 protein inhibitors show promising in-vivo efficacy'>Influenza matrix M1 protein inhibitors show promising in-vivo efficacy</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/virtual-identification-of-a-protein-target/' rel='bookmark' title='Virtual Identification of a Protein Target'>Virtual Identification of a Protein Target</a></li>
<li><a href='http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/' rel='bookmark' title='Drug resistance: evolution in action'>Drug resistance: evolution in action</a></li>
<li><a href='http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/' rel='bookmark' title='Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.'>Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2008 Quantum&#8217;s technology platform update and software releases</title>
		<link>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/</link>
		<comments>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/#comments</comments>
		<pubDate>Tue, 25 Nov 2008 11:26:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=45</guid>
		<description><![CDATA[It has been an exciting year here in Quantum Pharmaceuticals, another great year for our highly effective small molecule drug discovery and ADMET platform development. Our work is firmly based [...]


Related posts:<ol><li><a href='http://q-pharm.com/2008/10/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-updated-to-v-2-0/' rel='bookmark' title='q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is updated to v 2.0'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is updated to v 2.0</a></li>
<li><a href='http://q-pharm.com/2008/01/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-finally-released/' rel='bookmark' title='q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/adme-modeling/' rel='bookmark' title='ADME Modeling'>ADME Modeling</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/681-2/' rel='bookmark' title='LogP and LogD calculation'>LogP and LogD calculation</a></li>
<li><a href='http://q-pharm.com/2009/06/herg-binding-correlates-with-logp/' rel='bookmark' title='Does hERG binding correlate with LogP?'>Does hERG binding correlate with LogP?</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum Science Overview, v 0.1 has been released</title>
		<link>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/</link>
		<comments>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/#comments</comments>
		<pubDate>Tue, 18 Sep 2007 20:07:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=15</guid>
		<description><![CDATA[Quantum Pharmaceuticals is pleased to release Quantum Science Overview. The document conveys an overview Quantum&#8217;s drug discovery solutions and scientific results. The content of the report are summarized below:I. A [...]


Related posts:<ol><li><a href='http://q-pharm.com/2008/01/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-finally-released/' rel='bookmark' title='q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='QUANTUM and HSA binding calculations: the role of protein flexibility'>QUANTUM and HSA binding calculations: the role of protein flexibility</a></li>
<li><a href='http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/' rel='bookmark' title='From Biological Spectra (multiple protein binding data) to pharmacological profiling!'>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</a></li>
<li><a href='http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/' rel='bookmark' title='Protein flexibilty and ligand interaction complementarity example'>Protein flexibilty and ligand interaction complementarity example</a></li>
<li><a href='http://q-pharm.com/2008/01/herg-binding-prediction-quality-q-herg-model-vs-experiments/' rel='bookmark' title='HERG binding prediction quality: q-HERG model vs. experiments'>HERG binding prediction quality: q-HERG model vs. experiments</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular dynamics of HIV Integrase with an inhibitor</title>
		<link>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/</link>
		<comments>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/#comments</comments>
		<pubDate>Tue, 09 Jan 2007 09:15:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=8</guid>
		<description><![CDATA[Below we provide an example of Molecular Dynamics of HIV-integrase monomer with 1- (5- CHLOROINDOL-3- YL)-3 -HYDROXY-3 -(2H- TETRAZOL- 5- YL)-PROPENONE (pdb code 1qs4).

The protein structure is taken from the [...]


Related posts:<ol><li><a href='http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/' rel='bookmark' title='Protein flexibilty and ligand interaction complementarity example'>Protein flexibilty and ligand interaction complementarity example</a></li>
<li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2008/06/docking-validation-study-classic-example-thrombine/' rel='bookmark' title='Docking validation study: classic example, thrombine'>Docking validation study: classic example, thrombine</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protein flexibilty and ligand interaction complementarity example</title>
		<link>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/</link>
		<comments>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/#comments</comments>
		<pubDate>Sun, 10 Dec 2006 18:19:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=7</guid>
		<description><![CDATA[Human neutrophil elastase complexed with an inhibitor (gw475151) studied with QUANTUM normal modes analysis tools. The video shows the inhibitor (red licorice) remains in a strongly interacting position regardless of [...]


Related posts:<ol><li><a href='http://q-pharm.com/2007/05/quantum-free-energy-vs-statistical-scoring-functions/' rel='bookmark' title='QUANTUM free energy vs. statistical scoring functions'>QUANTUM free energy vs. statistical scoring functions</a></li>
<li><a href='http://q-pharm.com/2009/01/self-consistent-solvation-energy-contribution-calculation-for-protein-ligand-complexes/' rel='bookmark' title='Self-consistent solvation energy contribution calculation for protein-ligand complexes'>Self-consistent solvation energy contribution calculation for protein-ligand complexes</a></li>
<li><a href='http://q-pharm.com/2008/05/protein-flexibility-and-false-positives-detection/' rel='bookmark' title='Protein Flexibility and False Positives detection.'>Protein Flexibility and False Positives detection.</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/' rel='bookmark' title='Quantum Science Overview, v 0.1 has been released'>Quantum Science Overview, v 0.1 has been released</a></li>
<li><a href='http://q-pharm.com/2007/04/docking-selectivity-additive-vs-non-additive-force-field/' rel='bookmark' title='Docking selectivity: Additive vs. non-additive force field'>Docking selectivity: Additive vs. non-additive force field</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

